Skip to content
Search

Latest Stories

Salman Khan starrer Radhe gets U/A certificate

Salman Khan starrer Radhe gets U/A certificate

By Murtuza Iqbal

Salman Khan starrer Radhe: Your Most Wanted Bhai is one of the most awaited films of the year. It will be the first Bollywood film to get a multi-platform release.


Radhe will hit the big screens in India (in states where theatres are functioning) and overseas, and simultaneously it will release on OTT and DTH services.

Now, according to a report in PTI, the film has been given a U/A certificate by the Central Board of Film Certification (CBFC) without any cuts. The CBFC certificate, shared on the board's official website, gives out details about the movie.

Radhe certificate

The runtime of Radhe: Your Most Wanted Bhai is 114.24 minutes. This means Radhe’s runtime is less than two hours and tt will be one of the shortest films of Salman Khan.

Directed by Prabhudeva, Radhe is slated to release on Eid this year (13th May 2021). It also stars Disha Patani and Randeep Hooda. The trailer and the song Seeti Maar had failed to impress the audiences; however, the song Dil De Diya has received a great response.

Recently, the advance booking of the film kickstarted in UAE and Salman took to Twitter to inform his fans about it. He had tweeted, “#Radhe ki advance bookings ho gayi hain shuru for the UAE. Milte hain theatres mein. Stay safe! @voxcinemas @ReelCinemas @NovoCinemas @starcinemasme @CinepolisGulf and others.. @bindasbhidu @DishPatani @RandeepHooda @PDdancing @SKFilmsOfficial @SohailKhan @atulreellife.”

While announcing about the multi-platform release, Salman Khan Films in a statement had said, “It’s imperative that we all come together and think of out-of-the-box solutions for cinema as an industry during the current pandemic situation. We will support the theatre owners by releasing the film in as many theatres as we can, keeping in line with the rules and protocols laid down by the government. But, considering the guidelines and safety measures, we also need to devise ways to ensure that the film reaches all of our audience. We don't want to deny the audience the choice of entertainment in the comfort of their homes during these times."

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less